Guideline for the diagnosis and clinical management of oral submucous fibrosis

Title: Guideline for the diagnosis and clinical management of oral submucous fibrosis
Edition: Original
Classification: Standard guideline
Field: Comprehensive guideline
Countries and regions: China
Guidelines users: Clinicians, stomatologists, nurses, inspectors, policy makers and managers and other relevant professionals in various medical institutions in China
Evidence classification method: The evaluation of evidence quality System reviews and randomized controlled trials are considered as high-quality evidence (degraded according to the specific situation). Cohort studies are considered as medium-quality evidence (upgraded or degraded as appropriate). Case control study and case series analysis are considered as low-quality evidence. Case reports and expert opinions are considered as very low-quality evidence. This guideline does not use the results of animal experiments and in vitro experiments as evidence. Level of evidence Strong (a): Have strong confidence that the observed value is close to the true value, and further research will not change the credibility of the evaluation results of the intervention. Moderate (b): Have medium confidence in the observed value. The observed value may be close to the real value, but it may also be different. Further research is likely to affect the credibility of the evaluation results of the intervention and may change the evaluation results. Weak (c): The assurance of the observed value is limited, and the observed value may be very different from the real value. Further research is likely to affect the credibility of the evaluation results of the intervention and is likely to change the evaluation results. Very weak (d): There is little assurance about the observed value, and there may be a great difference between the observed value and the real value. The outcome of any assessment is uncertain.
Development unit: 中华口腔医学会
Registration time: 2022-05-15
Registration number: IPGRP-2022CN274
Purpose of the guideline: To standardize the diagnosis and clinical managements of oral submucosal fibrosis